Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Lexaria Bioscience (LEXX) Accumulated Depreciation & Amortization (2018 - 2026)

Lexaria Bioscience's Accumulated Depreciation & Amortization history spans 5 years, with the latest figure at $26014.0 for Q1 2026.

  • Quarterly results put Accumulated Depreciation & Amortization at $26014.0 for Q1 2026, up 48.95% from a year ago — trailing twelve months through Feb 2026 was $26014.0 (up 48.95% YoY), and the annual figure for FY2025 was $51225.0, up 20.68%.
  • Accumulated Depreciation & Amortization for Q1 2026 was $26014.0 at Lexaria Bioscience, down from $51225.0 in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $51225.0 in Q3 2025 to a low of $17465.0 in Q1 2025.
  • The 3-year median for Accumulated Depreciation & Amortization is $34231.0 (2024), against an average of $34288.0.
  • The sharpest move saw Accumulated Depreciation & Amortization rose 20.68% in 2025, then soared 48.95% in 2026.
  • Year by year, Accumulated Depreciation & Amortization stood at $42448.0 in 2024, then increased by 20.68% to $51225.0 in 2025, then tumbled by 49.22% to $26014.0 in 2026.
  • According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods came in at $26014.0, $51225.0, and $17465.0 for Q1 2026, Q3 2025, and Q1 2025 respectively.